<DOC>
	<DOCNO>NCT00579995</DOCNO>
	<brief_summary>The purpose study compare efficacy oral N-acetylcysteine intravenous sodium bicarbonate prevention CIN cardiac catheterization .</brief_summary>
	<brief_title>A Prospective , Randomized TrialComparing Oral N-Acetylcysteine Intravenous Sodium Bicarbonate</brief_title>
	<detailed_description>It think N-acetylcysteine may reduce ability generate oxygen free radical damage cell scavenge . N-acetylcysteine may also increase biologic effect nitric oxide combine nitric oxide form S-nitrosothiol , stable form potent vasodilator . It also increase expression nitric oxide synthesis may improve blood flow . Oxidants activate signal-transduction cascade molecular response may initiate cell-death pathway . These pathway seem sensitive redox state cell inhibit N-acetylcysteine , promote pathway lead repair survival whenever cell oxidant stress .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>19 year age Baseline serum creatinine Calculated creatinine Stable Renal Function Left Ventricular ejection fraction Nonpregnant , nonlactating female ( woman childbearing potential must negative serum pregnancy test . No contraception require Able sign inform consent Acute renal failure History Kidney transplant Currently receive Nacetylcysteine _ Contraindication hypersensitivity Nacetylcysteine sodium bicarbonate Left ventricular ejection fraction Pregnant , lactate female Allergy contrast dye</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>